A compound found in the spice turmeric may offer a new way to protect the heart in type 1 diabetes.
Researchers from the Florida Institute of Technology (FIT) have presented findings suggesting that curcumin, a compound found in turmeric, may mitigate cardiovascular damage associated with type 1 diabetes. The study, conducted on rats, will be presented at the American Physiology Summit in Minneapolis.
Key Details
- Over 40.1 million Americans have diabetes, with type 1 characterized by insufficient insulin production and type 2 linked to insulin resistance.
- The study used a rat model of type 1 diabetes to compare vascular function in rats that received curcumin versus those that did not.
- After one month, diabetic rats treated with curcumin showed improved vascular function, similar to non-diabetic rats.
- Curcumin reduced inflammation, balanced calcium ion flow in blood vessels, and increased a protein affected by diabetes.
Limitations
- The study was conducted on rats, not humans.
- Curcumin is poorly absorbed in the human gut and rapidly eliminated; it is often combined with other substances like black pepper to enhance bioavailability.
- Further research is needed to determine effective dosages and potential interactions with medications.
- Curcumin is already used for managing osteoarthritis and rheumatoid arthritis, and is being investigated for other inflammatory conditions.